It will be interesting in future research to determine whether the strength of galectin-3 interaction with the melanoma-derived MCAM is higher than its interaction with the recombinant form of MCAM using biophysical approaches such as isothermal titration calorimetry and surface plasmon resonance. The gene discussed is LGALS3; the disease is melanoma.